also mentions that A transition (approximately within 5–7 days) from an echinocandin to fluconazole is recommended if patients with candidemia fulfill the following criteria: The patient is no longer clinically unstable, the isolates are susceptible to fluconazole, and repeated blood cultures after initiated antifungal treatment have been negative. (not sure if pertinent info for step 1, maybe step 2)
more appropriate to leave as it was before but reorder and mention that amphotericin B is second line